Get the Stockscreener App
7.00
2.78%
-0.2004
Pre-market:
7.26
0.26
+3.71%
Addex Therapeutics Ltd Adr Stock (ADXN) Forecast
The Addex Therapeutics Ltd Adr (ADXN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.3078, representing a -81.32% decrease from the current price of $7.00. The highest analyst price target is $1.266, and the lowest is $1.3497.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADXN Price Target
Average 1.1681
(-83.31% Downside)
Is Addex Therapeutics Ltd Adr (ADXN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.38 | Neutral |
| STOCH(9,6) | 67.86 | Neutral |
| STOCHRSI(14) | 86.60 | Sell |
| MACD(12,26) | -0.0378 | Buy |
| ADX(14) | 16.24 | Neutral |
| William %R | -27.40 | Neutral |
| CCI(14) | 133.73 | Buy |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.5011
Buy
|
6.6668
Buy
|
| MA20 |
6.3483
Buy
|
6.6196
Buy
|
| MA50 |
7.0389
Sell
|
6.969
Buy
|
| MA100 |
7.6118
Sell
|
7.4345
Sell
|
| MA200 |
8.1811
Sell
|
7.7118
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ADXN could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on ADXN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.38 indicates that ADXN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 67.86 indicates that ADXN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 86.6 indicates that ADXN is oversold. This suggests that ADXN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.24 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 133.73 indicates that ADXN is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ADXN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Addex Therapeutics Ltd Adr financial reports and earnings history, Addex Therapeutics Ltd Adr (ADXN) stock could reach $1.2435 by 2030, $3.0029 by 2040 and $14.22 by 2050. See the projected annual prices until 2050 of the Addex Therapeutics Ltd Adr stock below:
- Addex Therapeutics Ltd Adr (ADXN) is expected to reach an average price of $6.379 in 2035, with a high prediction of $6.3433 and a low estimate of $6.1367. This indicates an $-8.87% rise from the last recorded price of $7.00.
- Addex Therapeutics Ltd Adr (ADXN) stock is projected to chart a bullish course in 2040, with an average price target of $0.7439, representing an $-89.37% surge from its current level. The forecast ranges from a conservative $0.5539 to a sky-high $3.0029.
- Our analysts predict Addex Therapeutics Ltd Adr (ADXN) to jump 4.36% by 2045, soaring from $7.0798 to an average price of $7.3052, potentially reaching $6.8252. While $7.0798 is the low estimate, the potential upside is significant.
- Addex Therapeutics Ltd Adr (ADXN) stock is expected to climb by 2050, reaching an average of $14.46, a $106.63% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.22 and $14.34, respectively, highlighting the market's uncertainty.
Addex Therapeutics Ltd Adr Stock (ADXN) Year by Year Forecast
Addex Therapeutics Ltd Adr Stock (ADXN) Price Forecast for 2026
The predicted value for Addex Therapeutics Ltd Adr (ADXN) in 2026 is set at an average of $1.5108. Estimates vary from a peak of $2.8034 to a trough of $0.2183, indicating an -78.42% surge from the present price of $7.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $1.4423 | $1.3497 | $1.266 | -79.40% |
| June, 2026 | $1.7121 | $1.4986 | $1.5074 | -75.54% |
| July, 2026 | $1.5888 | $1.7711 | $1.6725 | -77.30% |
| August, 2026 | $1.6241 | $1.6651 | $1.6314 | -76.80% |
| September, 2026 | $1.8404 | $1.688 | $1.7354 | -73.71% |
| October, 2026 | $1.5705 | $1.7905 | $1.8017 | -77.56% |
| November, 2026 | $0.9856 | $1.3656 | $1.5368 | -85.92% |
| December, 2026 | $0.5771 | $0.5345 | $0.8219 | -91.76% |
Addex Therapeutics Ltd Adr Stock (ADXN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Addex Therapeutics Ltd Adr (ADXN) is $6.1297, with a high forecast of $11.05 and a low forecast of $1.2134. This indicates an -12.43% decrease from the last price of $7.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.446 | $1.2134 | $1.1922 | -79.34% |
| February, 2027 | $1.6676 | $1.6973 | $1.5738 | -76.18% |
| March, 2027 | $1.7097 | $1.6462 | $1.6389 | -75.58% |
| April, 2027 | $1.6938 | $1.685 | $1.6776 | -75.80% |
| May, 2027 | $1.7547 | $1.7676 | $1.7365 | -74.93% |
| June, 2027 | $1.794 | $1.7746 | $1.7496 | -74.37% |
| July, 2027 | $1.8556 | $1.8467 | $1.842 | -73.49% |
| August, 2027 | $1.8408 | $1.8919 | $1.8519 | -73.70% |
| September, 2027 | $3.7889 | $1.9429 | $5.3404 | -45.87% |
| October, 2027 | $3.3027 | $2.8416 | $4.5453 | -52.82% |
| November, 2027 | $3.2176 | $2.7639 | $4.8859 | -54.03% |
| December, 2027 | $9.9462 | $3.2713 | $11.05 | +42.09% |
Addex Therapeutics Ltd Adr Stock (ADXN) Price Forecast for 2028
In 2028, Addex Therapeutics Ltd Adr (ADXN) is projected to reach an average price of $16.25, with a high projection of $29.23 and a low estimate of $3.2632. This indicates an +132.07% rise from the last price of $7.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.151 | $7.4665 | $11.29 | +16.44% |
| February, 2028 | $9.3159 | $6.5422 | $9.5887 | +33.08% |
| March, 2028 | $23.40 | $8.3196 | $25.73 | +234.35% |
| April, 2028 | $14.39 | $5.3456 | $23.44 | +105.60% |
| May, 2028 | $4.8076 | $4.8076 | $6.5725 | -31.32% |
| June, 2028 | $6.3816 | $3.9874 | $10.56 | -8.83% |
| July, 2028 | $4.9494 | $4.5494 | $29.23 | -29.29% |
| August, 2028 | $6.5766 | $4.6368 | $13.13 | -6.05% |
| September, 2028 | $5.3163 | $4.3614 | $6.624 | -24.05% |
| October, 2028 | $4.456 | $4.1287 | $5.3236 | -36.34% |
| November, 2028 | $4.0332 | $3.2632 | $5.1609 | -42.38% |
| December, 2028 | $5.6629 | $3.7481 | $5.8929 | -19.10% |
Addex Therapeutics Ltd Adr Stock (ADXN) Price Forecast for 2029
The 2029 price forecast for Addex Therapeutics Ltd Adr Stock (ADXN) is $2.7233 on average, with a high prediction of $5.4203 and a low estimate of $0.0263. This represents an -61.10% decrease from the previous price of $7.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.0801 | $3.8816 | $5.4203 | -41.71% |
| February, 2029 | $4.3498 | $3.4725 | $4.6575 | -37.86% |
| March, 2029 | $4.2345 | $3.7342 | $4.7372 | -39.51% |
| April, 2029 | $4.2393 | $3.5244 | $4.797 | -39.44% |
| May, 2029 | $2.4564 | $2.4564 | $3.9966 | -64.91% |
| June, 2029 | $1.7262 | $1.7262 | $3.3613 | -75.34% |
| July, 2029 | $1.1059 | $0.5859 | $2.3136 | -84.20% |
| August, 2029 | $0.643 | $0.643 | $1.8933 | -90.81% |
| September, 2029 | $0.0828 | $0.1971 | $1.0005 | -98.82% |
| October, 2029 | $0.4601 | $0.0263 | $0.9651 | -93.43% |
| November, 2029 | $0.1503 | $0.4576 | $0.2252 | -97.85% |
| December, 2029 | $0.2806 | $0.1529 | $0.2494 | -95.99% |
Addex Therapeutics Ltd Adr Stock (ADXN) Price Forecast for 2030
Addex Therapeutics Ltd Adr Stock (ADXN) is expected to reach an average price of $2.5935 in 2030, with a high forecast of $4.2533 and a low forecast of $0.9338. This signifies an -62.95% decrease from the last price of $7.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.4835 | $0.9338 | $1.2435 | -78.81% |
| February, 2030 | $3.6337 | $1.446 | $1.6037 | -48.09% |
| March, 2030 | $4.0139 | $3.9914 | $3.9225 | -42.66% |
| April, 2030 | $3.7743 | $3.9817 | $3.9366 | -46.08% |
| May, 2030 | $3.9871 | $3.8794 | $3.9371 | -43.04% |
| June, 2030 | $4.2076 | $4.0866 | $4.1579 | -39.89% |
| July, 2030 | $4.1202 | $4.1502 | $4.1651 | -41.14% |
| August, 2030 | $4.1255 | $4.1583 | $4.1128 | -41.06% |
| September, 2030 | $4.2958 | $4.1917 | $4.1908 | -38.63% |
| October, 2030 | $3.9968 | $4.1126 | $4.2533 | -42.90% |
| November, 2030 | $3.3839 | $3.7039 | $3.7562 | -51.66% |
| December, 2030 | $2.9841 | $2.949 | $2.6564 | -57.37% |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):